stars 1 stars 2 stars 3

CNSDose is a pharmacogenomic test that optimises mental health medication selection by incorporating genetics that influence both liver metabolism and blood-brain barrier efflux. CNSDose seeks to improve drug efficacy and reduce side-effects by helping clinicians select appropriate medications and doses based on a patients genetic profile.

CNSDose Questions

Hayden Pitout is the CTO of CNSDose.

4 people are employed at CNSDose.

CNSDose is based in Melbourne, Victoria.

Top CNSDose Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users